Edith Cowan University

Research Online
Theses : Honours

Theses

2002

Placental Peroxisome Proliferator-Activated Receptor Gamma and
Leptin Receptor in Human Pregnancy
Gwyneth H. Gladstones
Edith Cowan University

Follow this and additional works at: https://ro.ecu.edu.au/theses_hons
Part of the Obstetrics and Gynecology Commons

Recommended Citation
Gladstones, G. H. (2002). Placental Peroxisome Proliferator-Activated Receptor Gamma and Leptin
Receptor in Human Pregnancy. https://ro.ecu.edu.au/theses_hons/929

This Thesis is posted at Research Online.
https://ro.ecu.edu.au/theses_hons/929

Edith Cowan University
Copyright Warning

You may print or download ONE copy of this document for the purpose
of your own research or study.
The University does not authorize you to copy, communicate or
otherwise make available electronically to any other person any
copyright material contained on this site.
You are reminded of the following:
 Copyright owners are entitled to take legal action against persons
who infringe their copyright.
 A reproduction of material that is protected by copyright may be a
copyright infringement.
 A court may impose penalties and award damages in relation to
offences and infringements relating to copyright material. Higher
penalties may apply, and higher damages may be awarded, for
offences and infringements involving the conversion of material
into digital or electronic form.

Placental Peroxisome
Proliferator-Activated Receptor
gamma and Leptin Receptor in
Human Pregnancy

Gwyneth H. Gladstones

Supervised by:
Dr Peter Roberts & Dr Peter Burton

A Thesis Submitted in Partial Fulfilment of the Requirements for
the Award of

Bachelor of Science, Honours (Human Biology)

In the Faculty of Communications, Health and Science,
Edith Cowan University, Joondalup
15'" November 2002

USE OF THESIS

The Use of Thesis statement is not included in this version of the thesis.

ABSTRACT
leptin is a 16kDa peptide hormone that has recently been implicated in
human reproductive processes. like other hormones, leptin exerts its
ir.ftuence through its receptor. Of the three major isoforms of the receptor
(OB-Ra, OB-Rb, and 08-Re), OB-Ra (the dominant short form) has been
implicated in transport processes within rat and human placentas, suggesting
a role for it in implantation and pregnancy maintenance.
The peroxisome proliferator-activated receptors (PPARs) are liganddependent transcription factors that are a subfamily of nuclear hormone
receptors. PPARs form heterodimers with another nuclear hormone receptor,
RXRa, before binding to PPAR response elements (PPREs). Recently
PPARy/RXRa heterodimers have been implicated in trophoblast
differentiation, thus playing a key role in human implantalion and
placentation.
The present study used Western Blot analysis to quantify the presence of
Ob-R and PPARy protein in human placental tissue from first and second
trimesters, and at term (n=9, n=10, n=12 respectively). PPARy and OB-Ra
were found at ail stages of pregnancy. levels of 08-Ra were significantly
lower in second trimester than ·,n first trimester or at term (p<0.01, one-way
AN OVA). Interestingly, two different molecular weight (MW) protein bands of
PPARy were found, one at - SSkDa and another at -BOkDa. The 80kDa
PPARy protein decreased from first to second trimester and then increased
to maximal levels at term (F=14.437, p<0.0001, one-way ANOVA), and the
SSkDa PPARy protein was maximal in first trimester, fell in the second
trimester, and remained at this level until tenm (F=3. 793394, p<O.OS, one-way
ANOVA). Furthermore, the 80kDa protein was greater than the SSkDa at all
stages of pregnancy (first trimester p<O.OOS, second trimester p<0.0001,
term p<0.0001).
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The presence of 08-Ra and PPARy over the three stages of human
pregnancy demonstrates they are important in implantation and pregnancy
maintenance, and this may aid in our understanding pathological conditions
such as miscarriage and intrauterine growth retardation (IUGR).
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CHAPTER 1:

INTRODUCTION

14

1.1

BACKGROUND TO THE STUDY

Normal implantation and placentation are critical for a successful pregnancy.
Approximately 70% of all pregnancies fail to reach full term (Norwitz, Schust,
& Fisher, 2001 ). Of all pregnancies that are lost, 75% are due to failure of

implantation. Not only is implantation important but also maintenance of the
pregnancy after implantation is essential. The incidence of miscarriage after

implantation is estimated to be 25 to 40% (Norwitz et al., 2001). "The
maintenance of early pregnancy is inextricably linked with placental grov.th
and differentiation" (Norwitz et al., 2001, p.1405).
Successful implantation is the end result of complex molecular interactions
between the uterine endometrial epithelium and a blastocyst (Norwitz et al.,
2001). The blastocyst actively participates in a complex dialogue with the
endometrial lining during implantation and placental growth (Hill, 2001).
Important molecules in this communication process include cytokines, growth
factors, aJhesion molecules, apoptotic factors and angiogenic factors (Hill,

2001; Simon, Dominguez, Remohi, & Pellicer, 2001 ). Of these, the honmone
leptin and the group of nuclear hormone receptors known as peroxisome
proliferator-activated receptors (PPARs) are potentially important factors for
both implantation and pregnancy maintenance.
The hormone Leptin is a 16kDa peptide hormone and is a product of the
Obese (Ob) gene. The main site of leptin production is adipose tissue and it
was originally described as an adipocyte-derived signalling molecule,
involved in the control of body weight and energy expenditure (Auwerx &
Staels, 1998). Leptin exerts its effects through the leptin receptor (08-R)
(Tartaglia et al., 1995), and the mouse, rat and human placentas have been
shown to express leptin and leptin receptor (Masuzaki et al., 1997; Senaris et
al., 1997; Henson, Swan, & O'Neil, 1998; Smith & Waddell, 2002).
Recent studies have described important roles for leptin in reproduction and
neuroendocrine signalling (Auwerx & Staels, 1998; Cunningham, Clifton, &
Steiner, 1999; Moschos, Chan, & Mantzoros, 2002), and research has shown
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that human placental tissue synthesizes leptin (Senaris et al., 1997), and
leptin receptors are present in the human endometrium end decidua,
potentially participating in the implantation process (Simonet al., 2001).
Gonzalez et al. (2000) suggest that leptin and leptin receptors may be part of
the embryonic-endometrial dialogue during human embryo implantation.
Further evidence suggests that placentalleptin may be cru~,al for
angiogenesis, placental and fetal growth, and immunomodulation (Ashworth
etal., 2000; Hoggard, Haggarty, Thomas, & Lea, 2001). Furthermore, leptin
secretion has been demonstrated to be regulated by steroid hormones, and
this may link leptin with mechanisms supporting pregnancy maintenance
(Henson & Castracane, 2000).
PPARs comprise an important subfamily of the nuclear hormone receptor
superfamily (Rosen & Spiegelman, 2001 ). PPAR gamma (y) is a liganddependent nuclear hormone receptor that is involved in such pathways as
adipogenesis, control of cellular differentiation and proliferation, and the
maintenance of insulin sensitivity (Vamecq & Latruffe, 1999; Rosen &
Spiegelman, 2001). Barak et al. (1999), found PPARy to be crucial for
successful placentation in mice. These researchers found that PPARy
deficiency severely compromises maternal-fetal exchange functions.
Furthermore, PPARy null embryos showed evidence of myocardial thinning,
and PPARy was demonstrated to be necessary for normal placental
vascularisation (Barak et al., 1999).

1.2

SIGNIFICANCE OF THE STUDY

Infertility related to the process of implantation and poor placental growth is a
major problem in obstetric medicine, and implantation failure and miscarriage
are considered to be major biological causes of the low reproductive rate in
humans (Bulletti, Flamigni, & Giacomucci, 1996). There are variations in both
placental structure, and the process of embryo-maternal interactions between
species, and animal models are therefore often unreliable, and their
relevance to human implantation processes are unclear (Norwitz et al.,
2001). Human placental tissue will be used in this study in order to try and
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overcome some of these limitations, and identify the stage of human
pregnancy in which PPARy and OB-R are likely to have important roles. No
known studies to date have compared PPARy expression in normal human
placental tissue over the three trimesters of pregnancy, and only a few
studies have quantified the leptin receptor protein throughout human
pregnancy (Henson et al., 1998; Bodner et al., 1999).
It is necessary to understand the complex molecular mechanisms behind
normal human implantation processes so that factors which may be involved
in pathological conditions such as implantation failure, miscarriage and

intrauterine growth retardation (IUGR) may be identified. This may lead to
methods of improving the likelihood of a successful birth.

1.3

EXPERIMENTAL OBJECTIVE

The overall objective of this thesis was to use Western Blot analysis to
examine 08-R and PPARy protein expression over the course of human

pregnancy, to test the hypotheses that:
1. PPARy proteins are present in human placental tissues throughout
pregnancy.
2. OB-R and PPARy protein levels change throughout pregnancy.

3. PPARy and OB-R proteins have a role during the process of
implantation and pregnancy maintenance.

1.4

EXPERIMENTAL DESIGN

Human placental tissue was collected through first and second trimesters
and at term of pregnancy. PPARy protein and OB-R protein were measured
by Western Blot analysis at each stage.

17

CHAPTER2:

LITERATURE REVIEW
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2.1

IMPLANTATION

"Implantation of the blastocyst to the uterine wall represents a highly critical
point during early human gestation" (Sherer & Abulafia, 2001 p. 3).
Implantation involves four basic steps. (1) Apposition, or placement of the
blastocyst into the uterine cavity; (2) attachment of the blastocyst to the
endometrial surface epithelium; (3) invasion of the trophoblast into
endometrial tissues; and (4) growth of placental tissues, including
vasculogenesis and angiogenesis (Hill, 2001). Recent research
demonstrates that both maternal and embryonic factors have roles in the
implantation process (Hill, 2001; Sherer & ADJiafia, 2001; Simonet al.,
2001 ). The endometrium and blastocyst secrete hormones, cytokines, and
growth factors to prepare the uterus for implantation. Dysregulation of any

factors in this process may be involved in either failed implantation or
pregnancy failure (Hill, 2001; Simon et al., 2001 ). Progesterone and human
·;horionic gonadotrophin (hCG) are secreted in large amounts by the
syncytiotrophoblast and have a role in the trophoblast invasion (Bischof,
Meisser, & Campana, 2000). Trophoblast invasion is due to an active
biochemical process. According to Bischof, Meisser & Campana (2000), the
invasive behaviour of cytotrophoblastic cells (CTBs) is due to their ability to
secrete matrix metalloproteinases (MMPs), which are controlled by a tissue
inhibitor of MMPs (TIMP), that inhibits their invasiveness. MMPs are a family
of approximately seventeen human zinc-dependent endopeptidases
collectively capable of degrading all components of the extracellular matrix
(ECM) (Bischof et al., 2000). CTBs behave like metastatic cells except that
they are only transiently invasive (during the first trimester). This
invasiveness is normally limited to the endometrium and the proximal third of
the myometrium (Bischof et al., 2000). Hence, there is both temporal and
spatial regulation of invasion. Types of regulators involved in trophoblast·
endometrial reactions include hormones, cytokines, growth factors, ECM
glycoproteins, adhesion molecules, apoptotic factors, and angiogenic factors
(Bischof et al., 2000; Hill, 2001; Simonet al., 2001). Angiogenesis is the

development of new capillaries from existing vessels, and is essential for
normal implantation and placentation (Sherer & Abulafia, 2001 ). Abnormal
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angiogenesis has been implicated in disrupted implantation and placentation,
as well as early pregnancy loss. Certain angiogenic growth factors are now
known to be essential for angiogenesis, including vascular endothelial growth
factor (VEGF), placental growth factor (PIGF), platelet-derived growth factorAA (PDGF-AA), transforming growth factor a. (TGFa.), and TGFp (for review
see Sherer & Abulafta, 2001). Leptin, leptin receptor and PPARy have also
been implicated in this process (Sierra-Honigmann et al., 1998; Xin, Yang,
Kowalski, & Gerritsen, 1999)

2-2

DECIDUA

The decidua is the modified endometrium after implantation and is also the
functional layer of the pregnant endometrium (Moore & Persaud, 1993). The

decidua is formed following the endometrial reaction which occurs in
response to blastocyst implantation and subsequently leads to
decidualisation (Castellucci & Kaufmann, 1995). Decidualisation is

characterised by enlargement of the endometrial stromal cells, an increase in
the number and complexity of cytoplasmic organelles, and most importantly a

corresponding increase in secretory and synthetic activities of the
endometrium (Castellucci & Kaufmann, 1995).
There are three regions of the decidua; (1) the decidua basalis, which lies
deep to the conceptus and forms the maternal component of the placenta, (2)
the decidua capsularis; the superficial portion overlying the conceptus, which
degenerates and disappears by about week 22 of pregnancy, (3) the decidua
parietalis, which lines the uterine wall (Moore & Persaud, 1993).
The decidua is involved in the endometrial-embryonic dialogue during
implantation processes, and it has been postulated to be involved in
modulation of immune reactions during pregnancy. Lymphocytes make up
about 10% of all cells found in the decidua and most of these are natural
killer (NK) cells (Benirschke & Kaufmann, 1995).
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2.3

PLACENTATION

Following implantation, trophoblast cells pmliferate rapidly and invade the
surrounding endometrium. As the endometrium is invaded, maternal blood
vessels are trapped to form lacunae, which fill with maternal blood
(Cunningham, MacDonald, Gant, Leveno, & Gilstrap, 1993). As lacunae join,
a complicated lacunar network (labyrinth) is formed, which is partitioned by
trophoblastic columns and comprised of the intervillous space and primary
villous stalko, respectively (Cunningham et al., 1993), and is the beginning of
a primitive uteroplacental circulation. The lacunar network later becomes the
intervillous space of the mature human placenta (Moore & Persaud, 1993).
As invasion of the endometrium proceeds, two layers of trophoblast form; the
inner cytotrophoblast, and the outer syncytiotrophoblast (Moore & Persaud,
1993). PPARy is thought to be important in the process of trophoblast
differentiation (sP.e later). The syncytiotrophoblast (syncytium) is a
multinucleated mass without recognisable cell boundaries. It produces
secretions which enable the blastocyst to penetrate the endometrium (Moore
& Persaud, 1993), and lines the intervillous space, extending over surfaces of

all chorionic villi as well as over the inner surfaces of the chorionic and basal
plates. The syncytiotrophoblastic surface is almost entirely covered in
microvilli, that provide a vast maternal-fetal exchange zone. There have been
many studies of the structural and functional significance of this layer,

including research into surface enzymes, receptors for transplacental
hormones, growth factors, and immunological factors (for reviews see
Bischof et al., 2000; Norwitz et al., 2001). The cytotrophoblast is mitotically
active, and forms new cells that migrate into the syncytiotrophoblast. Here
the cells lose their membranes and become part of the syncytium (Moore &
Persaud, 1993). Thus, cytotrophoblastic cells are the stem cells of the
syncytium, supporting its growth and regeneration (Castellucci & Kaufmann,
1995).
Oxygenated blood and nutrients enter the lacunae from maternal spiral
arteries, and deoxygenated blood and waste products are removed via the
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veins of the uterus (Moore & Persaud, 1993). A fully mature maternal blood
circulation through the placenta may not develop until the end of the first
trimester, at about 10 to 12 weeks of the pregnancy (Johnson & Everitt,
2000).The maternal and fetal circulations pass clos~ to each other but do not
actually mix. In the intervillous space maternal blood flows around the fine
terminal villi containing fetal capillaries. Placental blood constitutes about
10% of the total maternal cardiac output by the end of the pregnancy
(Johnson & Everitt, 2000).Siow blood velocity in the spiral endometrial
arteries is thought to protect the early conceptus (pre-embryo) from being
dislodged by spurts of blood, as well as giving plenty of time for the exchange
of metabolites at the placental interface. A similar slowing of the blood occurs

on the fetal side of the circulation, where there is a massive expansion in
cross~sectional

area of blood vasculature due to a profusion of vascular

branching, and terminal capillary dilations (Johnson & Everitt, 2000). Nutrition
of the conceptus is initially histiotrophic (via uterine secretions and decidua),
and changes to haemotrophic as the placental blood supply develops
(Johnson & Everitt, 2000).

2.4

PLACENTAL GROWTH

As pregnancy progresses, the placenta grows more rapidly than the uterus
(Craven, Zhao, & Ward, 2000). The percentage of decidual surface area
occupied by the placenta increases from 3% in the first trimester to 26% by
the end of the pregnancy (Craven et al., 2000). The diameter of the placenta
grows from approximately 5 em at 11 weeks, to 28 em at 38 weeks (Craven
et al., 2000). Growth in thickness of the placenta continues until about the
eighteenth week of pregnancy with the increase in thickness being due to
branching of the stem villi (Moore & Persaud, 1993). Craven, Zhao, & Ward
(2000) propose that floating villi implant in decidual veins during early
pregnancy at sites distant from the existing placental bed, contributing to the
process of lateral placental growth. Thus, areas of decidua marginalis
become decidua basalis.
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2.5

THE MATURE HUMAN PLACENTA

The placenta is discoid in shape, with an average diameter of 22 centimetres.
It is approximately 2.5 centimetres thick at the centre and weighs on average
470 grams (Benirschke & Kaufmann, 1995).1t is 'haemomonochorial',
meaning that the trophoblastic surface is in direct contact with maternal blood
(Johnson & Everitt, 2000). It is also described as a 'chorio-allantoic' placenta,
which is one that develops from the blastocyst wall and becomes fully
vascularised from the allantois (the primitive embryonic bladder) (Johnson &
Everitt, 2000).
2.5.1

Placental Structure

The placenta is both a fetal and maternal organ and is made up of the
chorionic plate (fetal portion), and the basal plate (maternal portion), which
together enclose the intervillous space (Benirschke & Kaufmann, 1995). The
maternal surface has a 'cobblestone' appearance due to cotyledons (lobes)
visible on its surface and grooves on the surface are formed by placental
septa. The maternal surface is covered with maternal decidua basalis
(Johnson & Everitt, 2000).
The fetal surface is covered with amnion and attached to the chorionic plate.
Chorionic villi, which are vascularised with fetal blood project from tile
chorionic plate into the intervillous space. Here they are bathed in

matern~l

blood which circulates through the intervillous space (Benirschke &
Kaufmann, 1995). Some villi extend from the chorionic plate to the decidua
and serve as anchoring villi (Cunningham et al., 1993). Where the intervillous
space disappears at the placental margins, the chorionic plate and the fetal
plate fuse to form the chorion laeve (smooth chorion) (Benirschke &
Kaufmann, 1995).

2.6

VILLI

Anchoring villi (stem chorionic villi) anchor the chorionic sac and the placenta
to the decidua basalis, and the villous chorion is attached to the decidua
basalis by the cytotrophoblastic shell (Moore & Persaud, 1993). Within villi,
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fetal vessels are connected to the fetal circulatory system via the chorionic
plate and the umbilical cord (Benirschke & Kaufmann, 1995).
All villi have the same basic structure throughout the placenta, although
individual villi have been shown to have differing functional specifications.
Most fetal-maternal exchanges occur in placental villi, as well as the many
metabolic and endocrine activities of the placenla (Castellucci & Kaufmann,
1995). Within villi, fetal vessels are connected to the fetal circulatory system
via the chorionic plate and the umbilical cord (Benirschke & Kaufmann,
1995).
2.6.1

Development of Villi

Villi can be first distinguished by about the twelfth day after fertilisation
(Cunningham et al., 1993). These primary chorionic villi are finger-like
projections of the chorion (Moore & Persaud, 1993). Secondary chorionic villi
are formed early in the third week, when mesenchyme grows into the primary

chorionic villi and forms a core of loose connective tissue. Villi at this stage
cover the entire surface of the chorion (Moore & Persaud, 1993). Tertiary villi
(stem villi) are formed when angiogenesis occurs in the mesenchymal cells
(Cunningham et al., 1993). The blood vessels soon become connected with
the embryonic heart, and by the third week embryonic blood is circulating
through the capillaries of the chorionic villi (Moore & Persaud, 1993). Both
fetal and maternal blood vessels are now functional and placental circulation
is established (Cunningham et al., 1993).
Until the eighth week, chorionic villi cover the entire surface of the chorionic
sac. As the sac grows, the blood supply is reduced to a large proportion of
villi that eventually degenerate, producing the smooth chorion (chorion laeve)
(Moore & Persaud, 1993). At the same time, villi associated with the decidua
basil is (maternal component of the placenla) rapidly increase in number,
branch profusely, and enlarge. This area becomes the villous chorion
(chorion frondosum) and forms the fetal component of the placenta (Moore &
Persaud, 1993).
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2.6.2

Histological Structure of Villi

The layers of a villus externally to the core consist of syncytiotrophoblast,
villous cytotrophoblast (Langhan's cells), trophoblastic basement membrane,
and finally the stromal core of the villus (Castellucci & Kaufmann, 1995).
As described previously the syncytiotrophoblast is a continuous,
multinucleated layer that lines the intervillous space. It does not consist of

individual cells, and it is viewed as a single continuous structure (Moore &
Persaud, 1993).
Cytotrophoblastic cells (Langhan's cells) lie between the syncytiotrophoblast
and the basement membrane. As mentioned earlier they are the stem cells of
the syncytium, supporting its growth and regeneration. In early pregnancy,
this layer is nearly complete but later becomes discontinuous, as survival of
the syncytium depends on cytotrophoblastic fusion. Basement membrane
surrounds the stromal core of the villi. Its main function is to support the
trophoblastic epithelium. The villous stroma at the core of the villi is
composed of various types and amounts of connective tissue fibres, ground
substance, and fetal blood vessels (Castellucci & Kaufmann, 1995). Types of

fixed connective tissue cells in the villous stroma include;
mesenchymal cells, reticulum cells, fibroblasts, myofibroblasts, Hofbauer
cells, mast cells and plasma cells (Castellucci & Kaufmann, 1995).

2.7

PLACENTAL FUNCTION

The placenta is an endocrine organ that perfonms many diverse functions.
Firstly, it provides hormonal support for the developing embryo. Hormones
synthesised by the placenta include human chorionic gonadotropin (hCG),
human chorionic thyrotropin (hCT), human chorionic adrenocorticotropin
(hCACTH), progesterone, estrogen, relaxin, somatomammotrophins
including human placental lactogen (hPL), human growth hormone (hGH-V)
and prolactin (Benirschke & Kaufmann, 1995; Martini & Welch, 1998).
Secondly, it provides for the exchange of materials across the placental

interface by various transport processes. These materials include gases,
electrolytes, maternal hormones, waste products (urea, uric acid, bilirubin),
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water, glucose, steroid hormones, as well as drugs and infectious agents.
Thirdly, it performs many fetal metabolic functions as a substitute for the still

immature fetal organs, including gas transfer, excretory functions,
hematopoiesis, synthetic and secretory functions, and catabolic and
resorptive functions (Benirschke & Kaufmann, 1995).

2.8

INCIDENCE OF MISCARRIAGE

The probability of conceiving a clinically recognised pregnancy within a given
cycle has been estimated to be about 25%. However, this becomes closer to
32% when unrecognised pregnancies are included (Wilcox et al. cited in

Cramer & Wise, 2000, p. 333). This suggests that a number of infertile

women may actually be experiencing recurrent unrecognised pregnancy
losses (Cramer & Wise, 2000). The incidence of infertility is estimated to be
10 to 15% of all couples (Reyniak cited in Bulletti et al., 1996, p.119), and
some of this is due to implantation failure and early pregnancy loss.
Fertilization and the earliest development of the embryo do not lead
inevitably to a sustained pregnancy and successful birth. Loss of the human
conceptus is common and can occur at any stage of pregnancy (Johnson &
Everitt, 2000). Only 50 to 60% of all conceptions advance beyond 20 weeks
of gestation (Norwitz et al., 2001). Evidence suggests that up to 50% of all
conceptions produce zygotes that do not survive the cleavage stage (during
the first week after fertilisation), resulting in failure of implantation. Of those
embryos that have faulty implantation the average survival time is 8 weeks,
with 20% failing to complete 20 weeks of development (Martini & Welch,
1998). Failed embryo implantation is the cause of 75% of lost pregnancies,
which as a result often remain undetected. It is also a major cause of those
embryos lost in assisted reproduction (Norwitz et al., 2001).
Reproductive failure can also be due to spontaneous abortion (miscarriage)
or recurrent abortion. Recurrent abortion is usually diagnosed as at least
three consecutive miscarriages (Bulletti et al., 1996). The incidence of
pregnancy loss after successful implantation is estimated to be 25 to 40%
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-.
(Norwitz et al., 2001). The cumulative result of losses both before and after
implantation is that only 15 to 20% of human conceptions survive to a
successful birth (Johnson & Everitt, 2000).

2.9

AETIOLOGY OF MISCARRIAGE

Chromosomal anomalies are responsible for miscarriage in at least 50% of
all clinically recognised pregnancies, (Bulletti et al., 1996; Cramer & Wise,
2000; Johnson & Everitt, 2000). It has been suggested however, that the
largest single cause of pregnancy loss is through failure of implantation,
which has been estimated to be as high as 78% in humans (Webb & Glasser
cited in Bulletti et al., 1996, p. 120). Conceptus loss before implantation has
been attributed to a variety of reasons (for reviews see Bulletti et al., 1996;
Cramer & Wise, 2000).
Although a large percentage of recognised pregnancies fail due to
chromosomal anomalies, it is not known to what extent these anomalies
influence conceptus loss in unrecognised pregnancies. These pregnancies
possibly represent the highest percentage of human reproductive failure
(Bulletti et al., 1996; Norwitz et al., 2001). An overwhelming 40 to 60% of
miscarriages are of either uncertain or unknown origin (Bulletti et al., 1996;
Johnson & Everitt, 2000).

2.10

LEPTIN AND LEPTIN RECEPTOR (OB-R)

Leptin is a 16k0a hormone and is a product of the obese (Ob) gene. It was
first described as an adipocyte-derived signalling factor involved in the
control of body weight and energy expenditure (Auwerx & Staels, 1998;
Hoggard, Crabtree, Allstaff, Abramovich, & Haggarty, 2001). The main site of
leptin production is adipose tissue (Zhang et al., 1994), but it is also present
in other tissues. It has been found to be present in rat brain and pituitary
(Morash, Li, Murphy, Wilkinson, & Ur, 1999; Jin et al., 2000), the human
pituitary gland (Jin et al., 1999), the human and rat stomach (Bado et al.,
1998; Mix et al., 2000), and human mammary epithelial cells (Smith-Kirwin et
al., 1998). Masuzaki et al. (1997) and Senaris et al. (1997) were the first to
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report that leptin is synthesised in and secreted from the human placenta. In
vitro studies undertaken to measure leptin production by placental tissue

found that it produces large amounts of this hormone (Linnemann et al.,
2000). Recent studies have examined potential roles for placental leptin,

including fetal growth, immunomodulation, haematopoiesis and angiogenesis
(Auwerx & Staels, 1998; Sierra-Honigmann et al., 1998; Cao, Brackenhielm,
Wahlestedt, Thyberg, & Cao, 2001; Hoggard, Haggarty et al., 2001; Moschos
et al., 2002), and there is a large body of GVidence indicating that leptin has
roles in reproduction (Sabogal & Munoz, 2001; Moschos et al., 2002).
Observational studies have demonstrated that states of leptin excess,
deficiency, or resistance, may be associated with abnormal reproductive

function (For review see Moschos et al., 2002). Cheung et al. (1997)
demonstrated that in female rats leptin acted to restore the normal timing of
puberty following modest growth retardation imposed by food restriction.
Food restriction had already been shown to delay the onset of puberty
(Cheung et al., 1997). Similarly, when leptin was injected into normal
prepubertal female mice it caused an earlier onset of reproductive function

than in controls, suggesting that leptin acts as a signal triggering puberty
(Chebab, Mounzih, Lu, & Lim, 1997). Animal experiments and observational
studies indicate that a rise in leptin levels may be the earliest signal of the
onset of puberty and may contribute to the activation of the hypothalamicpituitary-gonadal (HPG) axis, resulting in an increase in sex steroid
production (Moschos et al., 2002). Recent studies show that leptin influences
the regulation of FSH, LH, ACTH, cortisol, and GH concentrations (Barash et
al., 1996; Jin et al., 1999; Ozata, Ozdemir, & Licinio, 1999), and leptin gene
expression itself is regulated by a variety of hormones, growth factors, and
cytokines (for review sre Moschos et al., 2002).
Leptin exerts its effects by interacting with its receptor (08-R) located in the
central nervous system and in peripheral tissues (Auwerx & Staels, 1998).
The leptin receptor belongs to the class 1 cytokine receptor family, and has
been found at all points along the HPG axis (Moschos et al., 2002),
suggesting that leptin plays an important role in the modulation of the
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reproductive axis (Cunningham et al., 1999). It has at least six splice variants
(08-Ra to 08-Rf), and the various isoforms have identical extracellular
domains, with either long (-300 amino acids), or short (-30 amino acids)
intracellular domains (da Silva, 8jorbaek, Uotani, & Flier, 1998; Cunningham
et al., 1999). 08-Ra, 08-Rb and 08-Re have been identified in the rat and
mouse placentas (Hoggard et al., 1997; Seeber, Smith, & Waddell, 2002;
Smith & Waddell, 2002). 08-Rb is the dominant long form of the receptor
and 08-Ra the dominant short form (Hoggard et al., 1997; Huang, Wang, &

li, 2001). 08-Re is the soluble form of the receptor and circulates in the
plasma (da Silva et al., 1998; Huang et al., 2001). OB-Rb is considered to be
the signalling form of the receptor (Ashworth et al., 2000), while 08-Ra is
thought to participate in transporting leptin across the blood-brain barrier, and
is expressed predominantly in the choroid plexus (Tartaglia, 1997). Smith &
Waddell (2002) suggest that placental expression of 08-Ra, 08-Rb, and
08-Re is likely to mediate leptin transport in the fetus and placenta. They
found that 08-Ra and 08-Re mRNA expression increased substantially in
the period of maximal growth in the rat placenta (Day 16 to Day 22), whereas
08-Rb remained relatively stable (Smith & Waddell, 2002). The increase in
08-Ra was specific to the site of maternal-fetal exchange (the placental
labyrinth zone) which they suggest is consistent with increased transport of
maternalleptin to the fetus in late pregnancy (Seeber et al., 2002).
Several studies have localised 08-R to the syncytiotrophoblast of the human
placenta by in situ hybridisation and immunohistochemistry. (Henson et al.,
1998; Bodner et al., 1999; Ashworth et al., 2000; Hoggard, Haggarty et al.,
2001). Bodner et al. (1999) comment that this indicates a role for the receptor

in the growth of the placenta and/or fetus, and Henson et al. (1998) suggest it

is indicative of the placenta's function as an endocrine organ. They
hypothesise that there is likely to be a regulatory association between leptin
and the steroid hormones, that may be basic to the maintenance of
pregnancy (Henson & Castracane, 2000).
Expression of leptin and 08-Rs in the human ovary, oocyte, endometrium,
embc•o, and placenta, implicate them in implantation and early embryonic
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development (Karlsson et al., 1997; Craven et al., 2000; Gonzalez et al.,
2000; Kitawaki et al., 2000; Sabogal & Munoz, 2001; Simonet al., 2001).
Kitawaki et al. (2000) were the first to demonstrate OB-R expression in the
human endometrium. They found leptin receptor expressed in decidual tissue
from early human gestation, and observed that whereas OB-R was
expressed in the human endometrium, leptin was not. They suggest that
leptin may play a specific role in interacting with other growth factors and
cytokines during the implantation process (Kitawaki et al., 2000). Gonza ••;_ et
al. (2000), demonstrated leptin and its receptor to be expressed in secretory
endometrium, and in cultured endometrial epithelial cells (EECs), and
suggest that leptin is part of the embryonic-endometrial dialogue during the
adhesion phase of human embryonic implantation. They hypothesise that the
blastocyst and endometrium may communicate during implantation through
leptin and its receptor. Simon &tal. (2001), reported that human blastocysts
and EECs secrete leptin, providing evidence to show leptin's presence and
regulation at the human embryonic and endometrial surface.
Interestingly, in a study comparing peripheral maternalleptin levels with
placentalleptin levels in baboon pregnancy, Henson et al. (1999) found
maternalleptin concentrations were positively corr1lated with gestational

age, whereas placentalleptin mRNA levels were negatively correlated with
gestational age. These differences may imply changing roles for leptin with
advancing pregnancy. The researchers comment that these changes are
likely to be common to baboon and human pregnancies (Henson et at.,
1999). Moreover, significantly lower concentrations of serum leptin observed
in women who subsequently miscarried suggest that leptin may have a role
in preventing miscarriage (Laird, Quinton, Anstie, Li, & Blakemore, 2001).
Malik et al. (2001) showed leptin to be a requirement for fertility, conception
and implantation in the mouse, but observed that once pregnancy was
established it was not required for maintenance of pregnancy. In contrast
Mounzih, Qui, Ewart-Toland, & Chebab (1998) found that leptin was not
essential for implantation, gestation, or fetal growth in mice, but it may be
implicated in the regulation of maternal nutrition and metabolic adaptation
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during pregnancy and lactation. They demonstrated a complete failure of
lactation in leptin-deficient (ob/ob) female mice.
Many studies to date have used mouse and rat models to investigate the
roles of leptin and its receptors in pregnancy. Due to the complexity of
interactions between leptin, OB-R, and other molecules, the utilisation of
animal models for the investigation of leptin action in human pregnancy has
produced conflicting results. As leptin action may differ significantly between
species, more human studies are warranted (Henson et al., 1998).

2.11

PEROXISOME PROLIFERATOR-ACTIVATED
RECEPTOR GAMMA (y)

Peroxisome proliferator-activated receptors (PPARs) were first discovered in
1990 (Vamecq & Latruffe, 1999). They are ligand-dependent transcription
factors belonging to the family of nuclear hormone receptors (Vamecq &
Latruffe, 1999; Rosen & Spiegelman, 2001). There are

thre~

major isoforms

of PPARs; PPARa., PPARP, and PPARy (Vamecq & Latruffe, 1999), that
together control many cellular and metabolic processes (Wahli, 2002).
PPARs have become an attractive target for pharmaceutical intervention in
such metabolic diseases as obesity, diabetes, and hyperlipidaemia, and
recently, they have been shown to have a role in epidermal differentiation
and repair (Wahli, 2002).

PPARy expression is dominant in white adipose tissue, and in immune cells
in rodents and humans (Fajas et al., 1997; Vamecq & Latruffe, 1999; Clark et
al., 2000; Padilla, Leung, & Phipps, 2002). PPARy forms heterodimers with
retinoid X receptors (RXRs) which then bind to PPAR-responsive elements
(PPRE) within the promoters of PPARy genes (Tarrade, Schoonjans,
Guibourdenche et al., 2001). Moreover, PPARy is involved in further complex

interactions with various ligands, coactivators, and corepressors (Vamecq &
Latruffe, 1999; Qi, Zhu, & Reddy, 2000; Rosen & Spiegelman, 2001 ), that
have yet to be fully understood. Interestingly, Western Blot studies of PPARy
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protein to date have reported finding PPARy protein at varying molecular
weights (see Table 1).
Table 1: Suggested PPARy Molecular Weights

PPARy
Molecular
Weight(MW)

Authors

Year

Tissue
examined

Capparuccia et al.

2002

human placenta

60kDa

Fajas et al.

1997

human adipose

60kDa

2002

human B cells

80kDa

2001

human placenta

57kDa

2001

human placenta

50kDa

2000

human placenta

55kDa

Padilla, Leung, &
Phipps
Tarrade,
Schoonjans,
Guibourdenche et
al.
Tarrade,
Schoonjans, Pavan
et al.
Waite et al.

Two isoforms of PPARy are found in mice and humans, PPARy 1 and
PPARy 2. Fajas et al. (1997) showed that the isoform PPARy1 is the
predominant form in humans. PPARy has been described as the 'master
regulator' of adipocyte differentiation (Vamecq & Lfltruffe, 1999, p.145), and it
promotes cell differentiation in many cell types incluaing hepatocytes,
fibroblasts, myocytes, keratinocytes, monocytes, and macrophages. PPARy
has been implicated in cancer, atherosclerosis, type 2 diabetes, the
regulation of insulin sensitivity and inflammatory responses (Vamecq &
Latruffe, 1999; Rosen & Spiegelman, 2001; Wahli, 2002).
Barak et al. (1999) showed PPARy to be necessary for normal placental
development in the mouse, and found PPARy deficiency caused an inability
of fetal blood vessels to form a vascular network. These authors
demonstrated that PPARy deficiency interferes with both trophoblast
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differentiation and placental vascularisation, leading to severe myocardial
thinning and death of the embryo (Barak et al., 1999). Fetal-maternal
exchange functions were severely compromised due to impaired
vascularisation. This study revealed a novel developmental dependence of
the heart on a functional placenta. Similar placental defects to those
mentioned occurring in PPARy null mice were observed in RXRa-deficient
mice (Wendling, Chambon, & Mark, 1999). Recent studies have implicated
PPARy in trophoblast differentiation in humans (Schaiff et al., 2000; Tarrade,
Schoonjans, Pavan et al., 2001). Furthermore, several studies have
investigated the role of PPARy in inhibiting angiogenesis. It has been found
to be expressed at high levels in tumour endothelium, and researchers have
demonstrated that PPARy ligands can inhibit primary tumour growth through
antiangiogenic effects (Xin et al., 1999; Panigrahy et al., 2002)
Recently, Cui et al. (2002), reported that the loss of the PPARy gene in
oocytes and granulosa cells led to impaired fertility. These researchers
commented that although progesterone levels were decreased, and
implantation rates reduced, they were not able to identify the exact
mechanisms involved.
PPARy has been localised by immunohistochemistry to human
syncytiotrophoblasts and cytotrophoblasts (Schaiff et al., 2000; Waite et al.,
2000; Tarrade, Schoonjans, Pavan et al., 2001; Capparuccia et al., 2002;
Wang, Fujii, & Knipp, 2002). Only a few studies have quantified PPARy
protein in placental tissue in human pregnancy. Wang et al. (2002) observed
PPARy in rat and human placentas. Tarrade, Schoonjans, Pavan et al.
(2001) measured PPARy in first trimester placentas only, and Schaiff et al.
(2000) in term placentas only. Recently, Capparuccia et at. (2002) observed
PPARy protein expression in early pregnancy and at term. These
researchers found no significant quantitative difference in PPARy expression
between first and third trimester placentas. Their results demonstcated that
PPARy expression was downregulated in gestational trophoblastic diseases
such as choriocarcinoma and hydatidiform moles, reinforcing earlier findings
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that PPARy is involved in the differentiation and invasiveness of placental
trophoblast cells (Barak et al., 1999; Schaiff et al., 2000; Tarrade,
Schoonjans, Pavan et al., 2001). Further studies are needed to elucidate the
role of PPARy over the course of human pregnancy.

2.12

PPARy- OB·R INTERACTION

Yamauchi et al. (2001) observed a potential interaction between leptin and
PPARy/RXRa heterodimers. The authors were examining the roles of these
receptors in insulin sensitivity, and reported that increases in PPARy/RXRa
activity were associated with decreased serum leptin levels (Yamauchi et al.,
2001). Indeed this may imply a similar pattern of expression in placental
function, and could be linked to recent evidence that PPARy/RXRa
heterodimers and OB·Ra are both involved in transport processes within the
placenta (Seeber et al., 2002; Smith & Waddell, 2002; Wang et al., 2002).

2.13

SUMMARY

Human embryo implantation and placental growth are vital to achieving a
successful birth. A deeper understanding is needed of the complex
interactions between molecules at the fetal-maternal interface. Recent
research indicates that leptin receptors and PPARy appear to hnve essential
roles in these communications. Deciphering these may contribute to reducing
the high incidence of unexplained infertility and miscarriage, by providing
possibilities for early clinical interventions in either pre-pregnancy or
pregnancy itself.
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CHAPTER3:

MATERIALS AND METHODS
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3.1

ETHICAL CONSIDERATIONS

Ethics approval was obtained for this study from Edith Cowan University
Faculty of Communications, Health and Science Ethics Sub-Committee for
the conduct of Human Research, and the King Edward Memorial and
Princess Margaret Hospitals Institutional Ethics Committees (EC 02·229).

3.2

TISSUE COLLECTION

Thirty-one samples of placental tissue were collected in total. Placental tissue
was obtained following caesarean deliveries, at term (n=12), from King
Edward Memorial Hospital, Subiaco, Western Australia. First trimester
placental tissue (n=9), was collected following elective terminations at
Nanyara, Rivervale, Western Australia, and second trimester placental tissue
(n=1 0), was collected following elective terminations from Marie Stapes
International, Midland, Western Australia. Term placentas were examined
and weighed prior to cutting several small samples (NO.Scm 3) from the
maternal surface which were then put into 1.5mL Eppendorf tubes, snap
frozen on liquid nitrogen, and stored at ·SO'C for later Western Blot analysis.
Due to the sensitive nature of, and the small amounts involved, first and
second trimester placental tissues were not examined or weighed. However,
as with term placentas, tissue was collected in 1.5mL Eppendorfs, snap
frozen on liquid nitrogen, and stored at ·SO'C for subsequent Western Blot
analysis. A patient information sheet was given to all patients and signed
consent was obtained prior to collection (see Appendices 1 and 2 for the
Form of Consent and Patient Information Sheet). First trimester placentas
were from gestational weeks 6, 7 (x4), 8 (x2), 9, and 11. Second trimester
placentas were from gestational weeks 13 (x2), 14, 15 (x3), 16, 17, 19 and
20.

3.3

PROTEIN EXTRACTION FOR WESTERN BLOT
ANALYSIS

Protein was extracted from placental tissues following a standard laboratory
protocol. Placental tissues were homogenised in RIP A Lysis Buffer (See
Solutions and Buffers for Western Blot in Appendix 4) using a Polytron PT
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1200 homogeniser ((Kinematica, Switzerland). One tablet of Complete,
EDTA-Free Protease Inhibitor Cocktail Tablets (Roche Diagnostics GmbH,
Mannheim, Germany), and 50)!1 of 0.1 M sodium orthovanodate were added
to 50)!1 of RIPA Lysis buffer immediately prior to homogenisation. The cell
lysate was then transferred to 1.5mL Eppendorf tubes and centrifuged at
11 000 x g at 4'C for 25 minutes. Following centrifugation the supernatant
was collected, aliquoted into 1.5mL Eppendorf tubes, and stored at -20'C. A
preliminary study found this protein fraction to be suitable for both leptin
receptor and PPARy detection.
3.3.1

Bradford Protein Assay

The Bradford protein assay was used to determine the total protein content of
the placental tissue protein extracts. This assay is a dye-binding assay in
which a colour change of dye occurs in response to various concentrations of
protein. It works by the action of Coomassie Brilliant blue G-250 dye (CBBG).
The absorbance maximum for a solution of CBBG shifts from 465nm to
595nm when binding to protein occurs.

3.3.1.1

Reagents

Bio-Rad Protein Assay Dye Reagent Concentrate and Bio-Rad Protein Assay
Standard II Lypophilised bovine serum albumin (BSA) were purchased from
Bio-Rad Laboratories, Hercules, USA.
3.3.1.2

Preparation of Standard Curve

The dye reagent was prepared by diluting 1 part Dye Reagent Concentrate
with 4 parts ddHzO and then filtered. Reconstituted BSA was mixed with
ddH 20 to a concentration of 1mg/mL. Cuvettes were set up in duplicate, and
a blank containing ddH 20 was prepared (see Table 3 in Appendix 3).
3.3. 1,3

Preparation of Protein Samples

Protein samples were taken out of -20'C storage, thawed on ice, diluted in
ddH 20, and prepared in duplicate. Preliminary studies were performed to
determine the correct dilution factor. Dilutions of 40x, 100x, and 250x were
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tested and a dilution factor of 1OOx was found to be suitable. However,
readings from eight samples did not fall within the standard curve and were
then diluted 200x which gave an acceptable concentration.
The 100x dilution was prepared by diluting

5~1

of protein sample in

ddH 20 and the 200x solution was prepared by adding
to

995~1

3.3.1.4

5~1

495~1

of protein sample

ddH 2 0.
Spectrophotometry

Semi-micro cuvettes, polystyrene, 1em path, 1.5mL, and a SmartSpec 3000
spectrophotometer were purchased from Bio-Rad Laboratcries, Hercules,
USA. Cuvettes for standard curve and cuvettes conteining diluted protein
samples were vortexed and incubated at room temperature for at least five
minutes before reading ir. the spectrophotometer. The spectrophotometer
was set to 595nm. The assay is monitored at 595nm and thus measures the
CBBG complex with the protein.

3.4
3.4.1

WESTERN BLOT ANALYSIS
Reagents

The Kaleidescope Prestained Standard (broad range, #161-0324), and
Prestained SDS-PAGE Standard (high range, #161-0309);Criterion Precast
gels 7.5% and 10% (forOB-R and PPARy respectively); running buffer, and
Laemmli sample buffer, were all purchased from Bio-Rad Laboratories,
Hercules, CA, USA. The premixed transfer buffer and p-mercaptoethanol
were from ICN Biornedicals, Aurora, Ohio, USA. Ponceau S solution was
from Sigma Chemical Co, StLouis, MO, USA; and Tween 20 from Asia
Pacific Specialty Ghemicals Ltd, Seven Hills, NSW.
3.4.2

Equipment

The Criterion Electrophoresis Cell Tank, Criterion Blotter Tank, PowerPac
200 power supply, Criterion Gel Holder Cassettes, Criterion Gel/Blot
Assembly Tray, lmmunu-Biot polyvinylidene diflouride (PVDF) membrane,
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filter paper and fibre pads (9.5x15.2cm), were all purchased from Bio-Rad
Laboratories, Hercules, CA, USA.
3.4.3

Buffers and Solutions

Buffers and solutions for Western Blot analysis were made up following
standard protocols, and are shown in Appendix 4.
3.4.4

Preparation of Samples for Gel Loading

Extracted protein samples were prepared for loading onto gels immediately
prior to loading. A total volume of 20fll was loaded into each well.
3.4.4.1

Reagents and Solutions

~-mercaptoethanol

was purchased from ICN Biomedicals Inc. Aurora, Ohio,

U.S.A. RIP A Lysis Buffer and Laemmli sample buffer were made to standard
protocols (See Appendix 4)
3.4.4.2

Calculation of Protein Extract to Load 100flg of Protein

For each orotein sample, the protein concentration for that sample
(spectrophotometer reading) was used to calculate the amount of protein (in
fll) to load for 1OOJ.lg. SJ.ll Laemmli sample buffer, containing 5%

~

mercaptoethanol was then added to that volume of protein, to which was
then added RIPA lysis buffer to a final volume of 20~tl.

~-mercaptoethanol

is

used to reduce disulphide linkages in solubilising proteins for gel
electrophoresis (see Table 2).
Table 2: Preparation of protein sample for loading
Protein
co7 cent~~on

Protein volume to
load for 1OOJJ.Q ().11)

e.a.40

2.5

1

ma/mL

Laemmli
Sample Buffer

RIPALysis

. f"ll

Buffer ("I)

5

12.5

Final
Volume

f"ll
20

Samples "ore then given a short vortex mix (-4 seconds) followed by a 6
second mini-spin. The protein samples, together with the appropriate

39

molecular weight marker (MW) were incubated at 55'C for 10 minutes prior
to loading onto gels.
3.4.5

Loading the Gels and Electrophoresis

Protein

(100~g)

was loaded into each lane, and the first lane in oach gel

contained 12 ~I of MW standard (broad range for PPARy and high range for
OB-R). The precast gels (10% for PPARy and 7.5% for OB-R) were set up in
the Criterion tank according to the manufacturer's instructions (Bio-Rad
Laboratories, Hercules, CA, USA.), and each gel was run at 80V for 20
minutes, and then at 150V for -80 minutes, until the dye front reached the
bottom of the gel.
3.4.6

Protein Transfer

Following electrophoresis, the gel was placed in transfer buffer for 15
minutes to equilibrate. The lmmuno-Biot PDVF membrane was placed in
100% methanol for a few seconds, until translucent, prior to transferring it to
transfer buffer to equilibrate. The Criterion Blotter transfer apparatus and
gel/membrane sandwich were prepared according to the manufacturers
instructions (Bio-Rad Laboratories, Hercules, CA, USA.), and the transfer
was run for 60 minutes at 1OOV on ice.
3.4.7

Ponceau S Staining

Membranes were removed from the transfer tank and placed in a shallow
dish filled with PBS and Tween. Ponceau S stain (4-SmL) was poured onto
the membranes to visualise and check for the even loading and transfer of
proteins. All dye was then removed from the membranes with multiple
washes in PBS and Tween.
3.4.8

PPARy and OB-R lmmunoblotting

Membranes were blcoked at room temperature in 0.01M PBS and Tween
containing 5% non-fat milk powder for one hour, and incubated overnight at
4'C with primary antibody (rabbit polyclonal antibody PPARy (H-100) SC7196, Santa Cruz Biotechnology, Santa Cruz, CA, USA), diluted 1:200 in
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blocking solution; or rabbit (OB-R PA 1-053, Affinity Bioreagents, Inc, Golden,
CO, USA), diluted 1:2000 in blocking solution. Membranes were then washed
5 times in 0.01 M PBS and Tween, and incubated at room temperature for 1
hour in secondary antibody (goat anti-rabbit lgG conjugated, SC-2030,
Santa Cruz Biotechnology, Santa Cruz, CA, USA) diluted 1:20 000 in
blocking solution. Membranes were then washed for 6 "5 minutes in 0.01M
PBS and Tween, followed by one rinse of- 20 seconds in 0.01M PBS
(without Tween).
3.4.9

Visualisation of Bands

Detection of bound antibody was performed with the enhanced
chemiluminescence Western Blotting detection kit (Amersham Pharmacia
Biotech UK ltd). The SuperSignal West Pico Substrate solution (Pierce
Chemical, Rockford IL, USA) was prepared by combining an equal volume of
l

Luminal/Enhancer solution and stable peroxide solution (to 10mL total).
Membranes were placed in the solution for 5 minutes with gentle shaking.
Membranes were then exposed to Hyperfilm ECL (Amersham Pharmacia
Biotech UK ltd) and Hypercassette 8" x 10" (Amersham Pharmacia Biotech
UK Ltd) for 1-10 minutes and developed on an Agfa Scopix LR 5200
developer. Membranes were stored at 4'C on 0.01M PBS prior to stripping
and reprobing.
3.4.10

Stripping and Reprobing the Membranes

Membranes were stripped by incubating in stripping solution (See Appendix
4) for 30 minutes at 70'C. They were then washed for 2 x 10 minutes in
0.01M PBS and Tween. The stripped membrane was then incubated (as
before) in SuperSignal West Pico Substrate working solution and exposed to
film. The membrane was considered stripped when no bands were visible
after 10 minutes exposure.
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3.4.10.1

Non-Specific Antibody Binding

To check for non-specific antibody binding, membranes were incubated
overnight at 4'C in blocking solution without the primary antibody, and then
proceeding as previously described (See section 3.4.8).
3.4.11

Quantification and Statistical Analysis

Bands on the immunoblot images were quantified using Scion Image
analysis (Scion Corporation, USA). All data are expressed as mean ±SEM.
Changes in quantities of PPARy and OB-R over the three stages of
pregnancy were determined by one-way AN OVA and Least Significant
Difference (LSD) tests. Differences in quantities of the different molecular
weights of PPARy protein (80kDa and 55kDa) in each trimester were
assessed by unpaired two tailed t-tests. A correlation analysis was performed
to assess possible relationships between (1) weeks of gestation and 80kDa
PPARy, (2) weeks of gestation and 55kDa PPARy, (3) weeks of gestation
and OB-Ra, (4) 80kDa PPARy and OB-Ra, and (5) 55kDa PPARy and
OB-Ra.
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4.1

WESTERN BLOT ANALYSIS OF PPARy PROTEIN

Western blot analysis showed the presence of both a high molecular weight
(MW) protein band of approximately 80kDa, and a less intense lower MW
protein band of approximately 55kDa over the three stages of pregnancy
(see Figure 1 ). No signals were detected in membranes that were not
exposed to primary antibody. The 80kDa band was more intense than the
55kDa band over all stages of pregnancy (first trimester 1=3.66, p<0.005;
second trimester 1=7.80, p<0.0001; term 1=21.74, p<0.0001, unpaired two
tailed t-test: see Figure 2). Quantification of the 80kDa PPARy protein signal
showed that it decreased from first to second trimester and then increased to
maximal levels at term (F=14.437, p<0.0001, one-way ANOVA; p<0.05,
p<0.001, p=0.0799, LSD test). The 55kDa PPARy protein signal was
maximal in first trimester, fell in second trimester and remained at this level at
term (F=3.793394, p<0.05, one-way ANOVA; p<0.05, p<0.05, p=0.733, LSD
tost).
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Figure 1. Western Blot of PPARy protein in human placental tissue over the
course of human pregnancy. Arrows on the left indicate the MW marker.
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Figure 2. Quantification of Placental PPARy protein (BOkDa band and 55kDa

band) over the three stages of human pregnancy. First trimester n;9, second
trimester n;1Q, term n;12. Bars indicate mean± SEM. At each stage of
pregnancy those values without common notations differ significantly.

4.2

CORRELATION BETWEEN GESTATIONAL AGE AND
PPARy

Because of the wide range of gestational ages examined, a correlation
analysis was performed to assess a possible association between the week
of gestation and level of PPARy. There was a significant positive correlation
between the 80kDa MW bands and weeks of gestation (r-0.5894, r';0,3474,
p;O.OOOS), and a significant negative correlation (r= -0.379, r';0.1436,
p<O.OS) between the amount of SSkDa protein and advancing gestation.
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4.3

WESTERN BLOT ANALYSIS FOR OB·Ra

Western blot analysis showed the presence of a 1OOkDa band corresponding
to the short form (08-Ra) of the leptin receptor, at all stages of pregnancy
(see Figure 3).
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Figure 3. Western Blot analysis of 08-Ra protein in human placental tissues
throughout human pregnancy. Arrows on the left represent the MW marker.
1OOkDa band is the 08-Ra protein.

Quantification of OB-Ra protein levels showed a significant decrease from
first trimester to second trimester, and then a significant increase back to
first trimester levels at term (F=5.73684, p<0.01, one-way AN OVA: see
Figure 4).
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Figure 4. Quantification of Placental OB-R protein over the three stages of

human pregnancy. First trimester n=9, second trimester n=10, term n=12.
Data expressed as mean ± SEM. Bars without common notations differ
significantly. OB-Ra protein levels changed significantly over the course of
pregnancy (F=5.73684, p<0.01, one-way ANOVA). Levels were lower in
second trimester compared to first trimester and term (p<0.05, p<0.05,
p=0.4070, LSD test).

4.4

CORRELATION BETWEEN GESTATIONAL AGE AND
OB-Ra

As with PPARy, a correlation analysis was performed to assess for a possible
relationship between gestational age and OB-Ra. There was no significant
correlation between OB-Ra and gestational age (r-0.2914, r'=0.0849,
p=0.1182, two tailed t-test).

4.5

COMPARISON OF BOkDa PPARy AND 08-Ra

Observations showed a similarity in the quantities of and pattern of the
PPARy BOkDa protein and OB-Ra over the three trimesters. To test if there
was an association between the two proteins, a correlation analysis was
performed showing a significant association (r-0.6937, r'=0.4812, p<0.0001,
two tailed 1-test). The same test performed on the 55kDa PPARy and OB-Ra
did not show a significant correlation (r-0.232, r'=0.0540, p=0.2168, two
tailed t-test).
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DISCUSSION

The experimental objective of this study was to examine OB-R and PPARy
protein expression throughout the course of human pregnancy. The present
study has shown the presence of two different molecular weights of PPARy
protein, at 55kDa and 80kDa respectively, over the three trimesters of
pregnancy, and OB-R protein at 1OOkDa representing the predominant short
form of leptin receptor, OB-Ra.
There was a significantly different pattern of 80kDa and 55kDa MW proteins
over the course of pregnancy, with the 80kDa protein increasing and the
55kDa protein decreasing as pregnancy advanced. The 80kDa PPARy
protein signal decreased from first to second trimester, then increased to
maximal levels at term. The 55kDa PPARy protein signal was maximal in first
trimester, fell in second trimester, and remained at this level until term.
Furthermore, there was a strong positive correlation between the 80kDa
protein and weeks of gestation, and a strong negative correlation between
the 55kDa protein and weeks of gestation.
Unlike previous studies (Fajas et al., 1997; Waite et al., 2000; Tarrade,
Schoonjans, Guibourdenche et al., 2001; Tarrade, Schoonjans, Pavan et al.,
2001; Capparuccia et al., 2002; Padilla et al., 2002), that have reported one
band at varying molecular weights in human placental tissue, the present
study showed evidence of two PPARy protein bands, at 55kDa and 80kDa.
These could possibly represent two PPARy isoforms. Further studies are
needed to fully characterise the two PPARy proteins identified in this study.
Molecular mechanisms involving PPARy/RXRa heterodimers, and their
interactions with ligands, coactivators, and corepressors are extremely

complex (Vamecc & Latruffe, 1999; Qi et al., 2000; Rosen & Spiegelman,
2001 ), and are beyond the scope of this thesis.
The presence of PPARy at all stages of pregnancy shown in this study
suggests a functional role for PPARy in implantation, and continuing
throughout pregnancy. Recent studies on human placental tissue have
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suggested a role for PPARy in trophoblast differentiation and invasion
(Schaiff et al., 2000; Tarrade, Schoonjans, Pavan et al., 2001; Capparuccia
et al., 2002). A significantly higher level of 55kDa PPARy protein was
observed in the first trimester compared to second and at term, as well as a
significantly higher level of BOkDa PPARy protein in the first trimester
compared to second. Early pregnancy is a crucial time for trophoblast
differentiation and invasion. Furthermore, these processes are essential for
successful implantation to occur.
OB-Ra protein was observed at all stages of pregnancy in the present study.
The results show no significant differences between levels of OB-Ra in the
first trimester and at term, similar to the observations of Henson et al. (1998)
who also examined first trimester and term human placental tissue and found
no difference. These authors however did not examine second trimester
placentas, unlike the present study showed that OB-Ra levels decrease
significantly in second trimester.
In the rat placenta, Smith & Waddell, (2002) found that OB-Ra protein
expression increased significantly from Day 16 to Day 22 (the period of
maximal growth; term ; Day 23). However, it is difficult to ascertain whether
Day 16 of rat pregnancy is equivalent to the first trimester or second trimester
in human pregnancy. If Day16 of rat pregnancy is the equivalent to second
trimester in human pregnancy then their findings support the findings of the
present study.
The functional importance of leptin and its receptors in human implantation
and pregnancy have been discussed recently in several studies, Ashworth et
al. (2000), and Hoggard, Haggarty et al. (2001 ), both describe roles for leptin
and its receptors in processes such as fetal growth, angiogenesis,
haematopoiesis, immunomodulation, and in numerous complex molecular
interactions at the fetal-maternal interface. The results of the present study
suggest an important functional role for the short form of the leptin receptor
in implantation and pregnancy. Higher levels of OB-Ra in first trimester and
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at term than in second trimester, suggest a functional role for the receptor at
these times. These roles are likely to be in angiogenesis in the first trimester,
and in transport functions between the placenta and mother and/or fetus at
term.
The present findings show a strong correlation between OB-Ra and PPARy
over all stages of pregnancy. Both PPARy and OB-Ra have been implicated
in angiogenesis (Sierra-Honigmann et al., 1998; Barak et al., 1999; Xin et al.,
1999; Ashworth et al., 2000; Hoggard, Haggarty et al., 2001; Panigrahy et al.,
2002) and placental transport functions (Vamecq & Latruffe, 1999; Seeber et
al., 2002; Smith & Waddell, 2002; Wang et al., 2002). The present study
raises the possibility of an interaction between OB-Ra and PPARy during
human embryo implantation and throughout pregnancy, in processes that are
essential to implantation and placentation.

5.2

LIMITATIONS OF THE STUDY

The present study could have been enhanced by examining placental OB-R
and PPARy mRNA expression by RT-PCR analysis. This however was not
feasible at this time due to difficulties encountered in obtaining placental
tissues, and delays in laboratory equipment set up.

5.3

FUTURE DIRECTIONS

Future directions for this study are firstly to investigate the regulation of
PPARy and OB-R in human pregnancy, and secondly to examine possible
interactions between them. The present study has contributed to our
understanding of normal placental ex. ·ession of OB-R and PPARy, which
may facilitate further studies of pathological conditions such as miscarriage
and IUGR. An unexpected result in this study was the presence of two
different molecular weight PPARy protein bands throughout pregnancy
(55kDa and 80kDa). Further characterisation of these bands is warranted.
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5.4

CONCLUSION

In conclusion, the present study has demonstrated the presence of both OBRa and PPARy protein over the three stages of human pregnancy. High
levels of each protein, in early human pregnancy and at term, suggest they
are important in human implantation and placentation as has been shown in
animal models. Functional roles for them are likely to be in angiogenesis,
placental transport processes and trophoblast differentiation. Furthermore,
this study has highlighted a possible interaction between PPI'.Ry and OB-Ra
in pregnancy. Further studies will focus on elucidating their regulation, and
investigating whether their downregulation is involved in pathological
conditions such as miscarriage and IUGR.
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7,1

APPENDIX 1

FORM OF CONSENT

I,
Given names

Surname

•

have read the information explaining the study entitles "Novel actions
of leptin in implantation and placental function".

•

have read and understood the information given to me. Any questions
I have asked have been answered to my satisfaction.

•

understand I may withdraw from the study at any stage and withdrawal
will not interfere with routine care.

•

agree that research data gathered from the results of this study may
be published, provided that names are not used.

Dated ........................ day of .......................................... 20 .............. .

Signature ...................................................... .

I, ..................................................... have explained the above to the
(Investigator's full name)

signatory who stated that he/she understood the same.

Signature ..................................................... .
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7.2 APPENDIX 2
PATIENT INFORMATION SHEET
Novel actions of leptin in implantation and placental function

Poor fetal growth and implantation failure remain major problems in obstetric
care. Successful implantation is where the embryo embeds itself in the lining
of the uterus and establishes a placenta. It is estimated that among human
conceptions that do not advance beyond midgestation, 75% are due to
implantation failure, and low birth weight accounts for 10% of annual child
health costs.

The establishment, growth and function of the placenta is of critical
importance to the successful maintenance and completion of pregnancy. The
placenta is effectively the lifeline of the growing fetus through its supply of
nutrients, removal of wastes and coordination of hormone signals that help
the fetus grow.
Among these signals a hormone called !eptin, which is better known for its
role in regulation of body weight has been identified as a crucial player in the
control of fetal growth. Another molecule known as PPAR has recently been
shown to be essential for implantation of the embryo into the uterus and the
establishment of a normal healthy placenta. In this study we will examine
leptin and PPAR in placental tissues from various stages of pregnancy and
in cases of poor fetal growth and miscarriage. We will use standard
laboratory procedures to measure the amount of these hormones in the
placenta.
The tests will then be done using small samples (3-4) about the size of a
thumbnail taken from the placenta after delivery. No information that can
identify you will be kept for these samples. No genetic information is being
studied. It is likely that the results will be published, but no way of identifying
you will be possible. Placentas will be disposed of following standard KEMH
procedures once the samples have been taken.
If you have any questions regarding this research project please contact
Dr Peter Burton
Scientific Director
Concept Fertility Centre
Telephone: 93822388
If you have any complaints regarding the conduct of the study please contact the
Executive Director of Medical Services at KEMH on 9340 2222
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7.3 APPENDIX 3
Table 3: Standard curve for the Bradford Protein Assay

STANDARD
No

PROTEIN
CONCENTRATION
Jmg/ml)

PROTEIN
STANDARD

1
2
3
4
5
6
7

0.00
0.10
0.20
0.40
0.60
0.80
1.00

0
2.5
5
10
15
20
25

ddH20

DILUTED
PROTEIN DYE
I" II

25
22.5
20
15
10
5
0

975
975
975
975
975
975
975

{ull

(The linear range of the Bio-Rad Bradford Protein Assay for BSA is
0.2-0.9 mg/ml.)
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7.4

APPENDIX 4

BUFFERS AND SOLUTIONS FOR PROTEIN EXTRACTION AND
WESTERN BLOT ANALYSIS
RIPA Lysis buffer
1.5M NaCI
1M Tris-HCI pH7.5
Triton-x-100
Deoxycholic Acid
10% SDS

100mL
50mL
10mL
5g
10mL

The volume was adjusted to 800ml with ddHzO, the pH was brought to 8.0
with 4M NaOH, and then the volume further adjusted to 1L with ddH 2 0.

Laemmli Sample Buffer
20% SDS
OTT
2.5M Tris pH 6.8
0.5M EDTA
glycerol
1% Bromophenol blue

6.25ml
0.77g
1.2mL
0.8ml
1.75ml
0.35ml

The volume was adjusted to 1Oml and the pH was brought to 6.8. 5!11 of Pmercaptoethanol was added to 95~1 of sample buffer prior to loading the
samples.

Running Buffer (1x Tris/Giycine/SDS)
0.025M Tris
0.192M Glycine
0.1% (w/v) SDS
100ml of 1Ox premixed buffer was added to 900ml of ddH 20. The pH was
brought to 8.3.

Transfer Buffer (Tris/Giycine)
0.025M Tris
0.0192M Glycine

1 packet of premixed buffer was added to 800ml methanol. The volume was
adjusted to 4L with ddH 20. The pH was brought to 8.3.
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0.01M PBS
NaH2PO,H20
Na2HPO,
NaCI

0.8g
S.Sg
35.7g

The volume was adjusted to 4L with ddH20. The pH was brought to 7.5.
4 mL of Tween was added to 4L of 01 M PBS.

5% (w/v) Blocking Solution
Skim milk powder (Sg) was added to 100mL 0.01M PBS and Tween.

Stripping Buffer
2.5M Tris-HCI pH 6.8
p-mercaptoethanol
SDS

25~1

9.98mL
20g

The volume was adjusted to 1000mL with ddH20.
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